Due to restrictions following results are derived from synthetic data to demonstrate capability of Computational Healthcare. Please do no derive any inferences from results below.
| Sex | Count |
|---|---|
| Female | 1110 |
| Sex unknown | 20 |
Minimum count is the lowest count allowed, all values lower than minimum are suppressed. Min hospital refers to the minimum number of hospitals from which each value must originate. E.g. if a specific combination occurs in only 3 hospitals and min_hospitals is 5 then the value is not shown.
| Aggregation Policy | |
|---|---|
| Minimum count | 20 |
| Multiple | 10 |
| Min hospitals | 2 |
| Min subset | 100 |
| Mean ΔT: 1.91 days | FQ: 1 days | Median: 2 days | TQ: 2 days |
some INFO
some INFO
| S1 | S2 | |
|---|---|---|
| Count | 580 | 550 |
| Sex : Female | 98.3% | 98.2% |
| Source : Routine, birth, etc | 15.5% | 16.4% |
| Source : Another hospital | 15.5% | 16.4% |
| Source : Another health facility including LTC | 15.5% | 16.4% |
| Source : Emergency department | 15.5% | 14.5% |
| Source : Unknown | 17.2% | 16.4% |
| Source : Court/Law enforcement | 17.2% | 16.4% |
| Disposition : Routine | 93.1% | 96.4% |
| Disposition : Home Health Care | 5.2% | 3.6% |
| Payer : Medicare | 15.5% | 14.5% |
| Payer : Medicaid | 13.8% | 14.5% |
| Payer : Private insurance | 12.1% | 12.7% |
| Payer : Self-pay | 13.8% | 14.5% |
| Payer : Other payer | 12.1% | 14.5% |
| Payer : Unknown payer | 12.1% | 14.5% |
| Payer : No charge | 12.1% | 10.9% |
| Race : White | 13.8% | 16.4% |
| Race : Black | 12.1% | 12.7% |
| Race : Hispanic | 15.5% | 9.1% |
| Race : Asian or Pacific Islander | 10.3% | 14.5% |
| Race : Native American | 15.5% | 14.5% |
| Race : Other | 13.8% | 14.5% |
| Race : Race missing, unknown | 13.8% | 14.5% |
| 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | |
|---|---|---|---|---|---|---|
| Count | 130 | 140 | 200 | 200 | 210 | 230 |
| Sex : Female | 92.3% | 92.9% | 100.0% | 100.0% | 100.0% | 95.7% |
| Source : Another hospital | 15.4% | 14.3% | 10.0% | 15.0% | 19.0% | 17.4% |
| Source : Another health facility including LTC | 15.4% | 14.3% | 15.0% | 15.0% | 19.0% | 8.7% |
| Source : Court/Law enforcement | 23.1% | 14.3% | 20.0% | 15.0% | 9.5% | 17.4% |
| Disposition : Routine | 100.0% | 92.9% | 95.0% | 95.0% | 95.2% | 95.7% |
| Payer : Medicare | 15.4% | 14.3% | 10.0% | 10.0% | 19.0% | 13.0% |
| Payer : Other payer | 15.4% | 14.3% | 10.0% | 10.0% | 9.5% | 17.4% |
| Payer : No charge | 15.4% | 0% | 15.0% | 10.0% | 9.5% | 8.7% |
| Race : Race missing, unknown | 15.4% | 0% | 15.0% | 10.0% | 9.5% | 13.0% |
| Source : Emergency department | 0% | 14.3% | 10.0% | 10.0% | 14.3% | 17.4% |
| Source : Unknown | 0% | 14.3% | 20.0% | 20.0% | 14.3% | 13.0% |
| Payer : Medicaid | 0% | 14.3% | 15.0% | 15.0% | 14.3% | 13.0% |
| Payer : Private insurance | 0% | 14.3% | 15.0% | 10.0% | 14.3% | 13.0% |
| Payer : Unknown payer | 0% | 14.3% | 15.0% | 10.0% | 14.3% | 0% |
| Race : Black | 0% | 14.3% | 10.0% | 15.0% | 9.5% | 8.7% |
| Race : Asian or Pacific Islander | 0% | 14.3% | 10.0% | 15.0% | 14.3% | 8.7% |
| Race : Native American | 0% | 21.4% | 15.0% | 10.0% | 14.3% | 17.4% |
| Source : Routine, birth, etc | 0% | 0% | 15.0% | 15.0% | 14.3% | 17.4% |
| Payer : Self-pay | 0% | 0% | 15.0% | 15.0% | 9.5% | 17.4% |
| Race : White | 0% | 0% | 15.0% | 20.0% | 14.3% | 13.0% |
| Race : Other | 0% | 0% | 20.0% | 10.0% | 14.3% | 13.0% |
| Race : Hispanic | 0% | 0% | 10.0% | 10.0% | 14.3% | 8.7% |
| Age | Count |
|---|---|
| 80 - 99 | 30 |
| 40 - 59 | 640 |
| 60 - 79 | 410 |
| 20 - 39 | 50 |
| Mean age | First quartile | Median | Third quartile |
|---|---|---|---|
| 56.95 years | 49 years | 56 years | 65 years |
| 45 >= Age > 20 | 65 >= Age > 45 | 85 >= Age > 65 | |
|---|---|---|---|
| Count | 160 | 710 | 250 |
| Sex : Female | 100.0% | 97.2% | 100.0% |
| Source : Court/Law enforcement | 18.8% | 15.5% | 20.0% |
| Source : Routine, birth, etc | 12.5% | 15.5% | 16.0% |
| Source : Another hospital | 18.8% | 15.5% | 16.0% |
| Source : Another health facility including LTC | 12.5% | 16.9% | 12.0% |
| Source : Emergency department | 0% | 15.5% | 16.0% |
| Source : Unknown | 18.8% | 16.9% | 12.0% |
| Disposition : Routine | 93.8% | 94.4% | 96.0% |
| Payer : Medicare | 12.5% | 15.5% | 16.0% |
| Payer : Medicaid | 0% | 15.5% | 16.0% |
| Payer : Private insurance | 0% | 12.7% | 12.0% |
| Payer : Self-pay | 12.5% | 14.1% | 12.0% |
| Payer : Other payer | 18.8% | 12.7% | 12.0% |
| Payer : Unknown payer | 18.8% | 12.7% | 12.0% |
| Payer : No charge | 0% | 14.1% | 8.0% |
| Race : White | 12.5% | 15.5% | 12.0% |
| Race : Black | 12.5% | 11.3% | 16.0% |
| Race : Hispanic | 12.5% | 12.7% | 12.0% |
| Race : Asian or Pacific Islander | 12.5% | 12.7% | 12.0% |
| Race : Native American | 12.5% | 15.5% | 12.0% |
| Race : Other | 12.5% | 14.1% | 12.0% |
| Race : Race missing, unknown | 0% | 14.1% | 16.0% |
| Sex : Sex unknown | 0% | 2.8% | 0% |
| Disposition : Home Health Care | 0% | 4.2% | 0% |
| Procedure Code | Description | Count |
|---|---|---|
| P4023 | Excision of axillary lymph node | 270 |
| P9216 | Scan of lymphatic system | 20 |
| P8595_2 | Insertion of breast tissue expander 2nd | 350 |
| P8571 | Latissimus dorsi myocutaneous flap | 30 |
| P8595 | Insertion of breast tissue expander | 1140 |
| P8536 | Other bilateral subcutaneous mammectomy | 100 |
| P8553 | Unilateral breast implant | 20 |
| P8543 | Unilateral extended simple mastectomy | 260 |
| P8589_2 | Other mammoplasty 2nd | 60 |
| P8544 | Bilateral extended simple mastectomy | 70 |
| P8534 | Other unilateral subcutaneous mammectomy | 100 |
| P4019 | Other diagnostic procedures on lymphatic structures | 70 |
| P8541 | Unilateral simple mastectomy | 270 |
| P8605 | Incision with removal of foreign body or device from skin and subcutaneous tissue | 20 |
| P4011 | Biopsy of lymphatic structure | 110 |
| P8589 | Other mammoplasty | 410 |
| P8594 | Removal of implant of breast | 50 |
| P8585 | Muscle flap graft to breast | 40 |
| P403 | Regional lymph node excision | 20 |
| P8542 | Bilateral simple mastectomy | 240 |
| P8554 | Bilateral breast implant | 20 |
| DRG Code | Description | Count |
|---|---|---|
| DG461 | DRG V24 : O.R. PROC W DIAGNOSES OF OTHER CONTACT W HEALTH SERVICES | 40 |
| DG258 | DRG V24 : TOTAL MASTECTOMY FOR MALIGNANCY W/O CC | 590 |
| DG261 | DRG V24 : BREAST PROC FOR NON-MALIGNANCY EXCEPT BIOPSY & LOCAL EXCISION | 110 |
| DG265 | DRG V24 : SKIN GRAFT &/OR DEBRID EXCEPT FOR SKIN ULCER OR CELLULITIS W CC | 30 |
| DG257 | DRG V24 : TOTAL MASTECTOMY FOR MALIGNANCY W CC | 250 |
| DG266 | DRG V24 : SKIN GRAFT &/OR DEBRID EXCEPT FOR SKIN ULCER OR CELLULITIS W/O CC | 60 |
| Diagnosis Code | Description | Primary | POA | All |
|---|---|---|---|---|
| D25000 | Diabetes mellitus without mention of complication, type II or unspecified type, not stated as uncontrolled | 0 | 0 | 30 |
| DV4571 | Acquired absence of breast and nipple | 40 | 0 | 100 |
| D4019 | Unspecified essential hypertension | 0 | 0 | 190 |
| D34690 | Migraine, unspecified, without mention of intractable migraine without mention of status migrainosus | 0 | 0 | 20 |
| D311 | Depressive disorder, not elsewhere classified | 0 | 0 | 40 |
| DV5041 | Prophylactic breast removal | 70 | 0 | 160 |
| D1749 | Malignant neoplasm of breast (female), unspecified | 240 | 0 | 230 |
| DV8401 | Genetic susceptibility to malignant neoplasm of breast | 0 | 0 | 20 |
| D2449 | Unspecified acquired hypothyroidism | 0 | 0 | 90 |
| D1741 | Malignant neoplasm of central portion of female breast | 30 | 0 | 30 |
| D30000 | Anxiety state, unspecified | 0 | 0 | 40 |
| D1742 | Malignant neoplasm of upper-inner quadrant of female breast | 40 | 0 | 40 |
| D1745 | Malignant neoplasm of lower-outer quadrant of female breast | 30 | 0 | 30 |
| D1744 | Malignant neoplasm of upper-outer quadrant of female breast | 130 | 0 | 110 |
| DV153 | Personal history of irradiation, presenting hazards to health | 0 | 0 | 40 |
| D6101 | Diffuse cystic mastopathy | 0 | 0 | 40 |
| DV510 | Encounter for breast reconstruction following mastectomy | 20 | 0 | 0 |
| D3051 | Tobacco use disorder | 0 | 0 | 30 |
| D1748 | Malignant neoplasm of other specified sites of female breast | 200 | 0 | 190 |
| DV861 | Estrogen receptor negative status [ER-] | 0 | 0 | 20 |
| DV860 | Estrogen receptor positive status [ER+] | 0 | 0 | 100 |
| D2720 | Pure hypercholesterolemia | 0 | 0 | 50 |
| D2330 | Carcinoma in situ of breast | 200 | 0 | 240 |
| D2724 | Other and unspecified hyperlipidemia | 0 | 0 | 40 |
| DV103 | Personal history of malignant neoplasm of breast | 0 | 0 | 130 |
| DV1582 | Personal history of tobacco use | 0 | 0 | 70 |
| DV8741 | Personal history of antineoplastic chemotherapy | 0 | 0 | 20 |
| DV163 | Family history of malignant neoplasm of breast | 0 | 0 | 160 |
| D49390 | Asthma, unspecified type, unspecified | 0 | 0 | 50 |
| D1963 | Secondary and unspecified malignant neoplasm of lymph nodes of axilla and upper limb | 0 | 0 | 150 |
| D78702 | Nausea alone | 0 | 0 | 20 |
| D217 | Benign neoplasm of breast | 0 | 0 | 20 |
| D6111 | Hypertrophy of breast | 0 | 0 | 20 |
| D27800 | Obesity, unspecified | 0 | 0 | 20 |
| D53081 | Esophageal reflux | 0 | 0 | 70 |